77
40
Growth Score
-8 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
299611
Dexcel Pharma is an international specialty pharmaceutical company.
Ilan Oren: Vice President, Business Development- Tzuki Harush: Vice President, Finance and Chief Financial Officer
About the Company
Dexcel Pharma is Israel’s largest private pharmaceutical company. Founded in 1968, they develop, manufacture and market value-added branded and generic pharmaceuticals. With a diverse product portfolio that spans more than 55 branded and generic products in over 140 dosage forms, our products are sold in the US, the UK, and Germany, via
subsidiaries and through a trusted network of partners in more than 30 countries worldwide.
